Career & background
She joined Pharmaniaga in 2023, with portfolio experience covering diabetes, antivirals, gastroenterology and alimentary products. The source dates her expanded team remit from June 2026. She holds a PhD in Medical Biotechnology from the University of Malaya, with research on mushroom-related cholesterol reduction in rats, and an MSc in Plant Pathology from Universiti Sains Malaysia.
Areas of contribution
Her activities include professional education concerning Tegoprazan, marketed as K-CAB, and speaking at the Pexlift engagement described in the source. She has appeared in Utusan Malaysia and mentored students from Swinburne Australia, Monash and Sunway through FutureLab, alongside guest speaking for Monash pharmacy.
Leadership focus
Her professional interests connect research interpretation with pharmaceutical-product strategy and communication with healthcare practitioners. Mentoring provides a parallel way to share scientific and industry experience with students.
The basis of this profile.
This profile brings together factual career information from publicly available sources. References and publication dates are provided below.
Kepimpinan Malaysia26 Oct 2026 · Read the original publicationThe source also uses the name Dr. Faz. Its Malaysia Book of Records reference concerns the Pexlift engagement, rather than a separately specified individual award; the doctoral research described is preclinical.
Professional details reflect the cited publication dates and may change. Third-party materials remain subject to their owners’ rights.
